RT info:eu-repo/semantics/article
T1 Diacutaneous fibrolysis intervention in patients with mild to moderate carpal tunnel syndrome may avoid severe cases in elderly: A randomized controlled trial
A1 Jiménez del Barrio, Sandra
A1 Ceballos Laita, Luis
A1 Bueno Gracia, Elena
A1 Rodríguez Marco, Sonia
A1 Caudevilla Polo, Santos
A1 Estébanez de Miguel, Elena
K1 Ultrasonic imaging
K1 Ultrasonography
K1 Ultrasonografía
K1 Physical therapy
K1 Traumatology
K1 Orthopedics
K1 Wrist - Wounds and injuries
K1 Muñeca (Anatomia) -  Lesiones y heridas
K1 Hand - Wounds and injuries
K1 Mano - Lesiones y heridas
K1 Carpal Tunnel Syndrome
K1 Síndrome del túnel carpiano
K1 Diacutaneous Fibrolysis
K1 Fibrólisis diacutánea
K1 3213.11 Fisioterapia
K1 3213.15 Traumatología
AB Background: Carpal Tunnel Syndrome (CTS) mainly affects adults of working age. The prevalence of severe cases is higher in elderly patients (>65 years old). Clinical guidelines recommend conservative treatment as the best option in the initial stages of CTS to avoid severe cases. Diacutaneous Fibrolysis (DF) has demonstrated to improve nerve conduction studies and mechanosensitivity. The main purpose was to quantify changes in the cross-sectional area (CSA) of the median nerve, transversal carpal ligament (TCL) thickness, numbness intensity, and the subjective assessment of clinical change after DF treatment in patients with CTS. Methods: a double-blind, randomized, placebo-controlled trial was designed. A number of 44 patients (60 wrists) with CTS were randomized to the DF group or the sham group. CSA and TCL thickness variables were registered by ultrasound. Clinical variables were assessed by the visual analogue scale and GROC scale. SPSS version 24.0 for MAC was used for statistical analysis. The group by time interaction between groups was analyzed using two-way repeated measures analysis of variance. Results: The DF group reduced CSA with a mean of 0.45 mm2 (IC 95% 0.05 to 0.86) and TCL thickness with a mean reduction of 0.4 mm (IC 95% 0.6 to 2.1) compared to the sham group (p < 0.01, p < 0,03, respectively). Additionally, the DF group decreased the numbness intensity with a mean reduction of 3.47 (IC 95% 2.50 to 4.44, p < 0.01) and showed a statistically significant improvement on the GROC scale (p < 0.01). Conclusions: DF treatment may significantly reduce CSA and TCL thickness, numbness intensity, and improved clinical perspective. DF applied in patients with mild to moderate CTS may prevent the progression of the disease as they age.
PB MDPI
SN 1660-4601
YR 2022
FD 2022
LK https://uvadoc.uva.es/handle/10324/61201
UL https://uvadoc.uva.es/handle/10324/61201
LA eng
NO International Journal of Environmental Research and Public Health, 2022, Vol. 19, Nº. 17, 10983
NO Producción Científica
DS UVaDOC
RD 23-nov-2024